Roche Scales NVIDIA AI Factories Globally for Drug Discovery

Pharmaceutical giant Roche is making a monumental bet on artificial intelligence, announcing a global deployment of more than 3,500 NVIDIA Blackwell GPUs. This massive investment aims to supercharge every stage of its value chain, from initial research to final manufacturing. The initiative, described as scaling "AI factories" worldwide, is designed to dramatically accelerate the discovery of new drugs and diagnostic solutions. By integrating this advanced computing power across its operations, Roche seeks to achieve a significant boost in R&D productivity. The goal is to shorten the traditionally long and costly drug development timeline. Furthermore, the company plans to leverage the AI infrastructure to enable next-generation diagnostics and improve the efficiency of its manufacturing processes. This move underscores the life sciences industry's growing reliance on high-performance computing to solve complex biological puzzles and bring treatments to patients faster.